Skip to content
Showing 71 - 80 of 1529 results.
Dr. Carl Hart talks about his work on the science of drug and cannabis addiction.
We spoke with David Hellerstein, MD, Director, Depression Evaluation Service, Columbia University Department of Psychiatry, about his Ganaxolone for postpartum depression study.
“Part of the problem that we’re faced within the field is that we really need to become better at identifying the factors that lead to the escalation of suicide risk,” says Dr. Randy Auerbach,
Dr. Drew Ramsey is a pioneer in the field of nutritional psychiatry, which attempts to apply what science is learning about the impact of nutrition on the brain and mental health.
Media coverage of suicide that focuses on recovery and healing has been proven to reduce risk among vulnerable members of a community—a phenomenon Dr. Madelyn Gould refers to as the “Papageno effect.”
Dr. Jeffrey A. Lieberman, said young people are particularly susceptible to the after-effects of trauma.
“It’s the first time that we know what questions indicate who’s at imminent risk, the very few people who actually need a next step,” says Dr. Kelly Posner Gerstenhaber of the Columbia Protocol.
For the last two and a half decades, Dr. J. John Mann and his collaborators have been working to characterize brain abnormalities associated with suicide.
In addition to therapy, Nancy Turret has always been passionate about photography.
"People tend to tip-toe around sensitive issues like suicide. You shouldn't. You're not going to prompt someone to do it by asking them," said Dr. Jeffrey Lieberman.